Aier Ophthalmology was awarded the title of "Model of Technological Innovation"

On August 7th, the "New Express, Good and Upward" New Express 2026 ESG Ceremony was held in Guangzhou, and the list of "Technological Innovation Models" was officially announced. Aier Ophthalmology drives industrial upgrading with innovation, adheres to the core of technology for good, and ultimately successfully won this honor, becoming an excellent example of sustainable development for enterprises.

Technological innovation is an important driving force for promoting high-quality development of enterprises. Aier Ophthalmology always adheres to the core strategy of "innovation driven, technology driven", guided by "improving medical quality, enhancing clinical efficiency, and promoting industrial upgrading". It insists on building a professional foundation, accumulating energy through innovation, and gathering strength through collaboration, continuously consolidating the foundation of disciplinary development, gathering industry wisdom, enhancing high-quality development momentum, constantly strengthening innovation capabilities, promoting the deep integration of cutting-edge technology, scientific research achievements, and clinical practice, and actively working with all parties to promote industry exchanges, cooperation, and collaborative progress.

A comprehensive science and technology innovation platform system is the underlying support for continuously producing innovative results. At present, Aier Ophthalmology has established an integrated innovation platform system for medical research and teaching, consisting of "multiple hospitals, multiple institutes, four stations, seven centers, five bases, two platforms, and one office". It has achieved full chain talent cultivation and incubation from undergraduate to postdoctoral, forging a solid talent pool and technical support for its high-quality development, and continuously injecting inexhaustible momentum into the innovation breakthroughs and new quality productivity cultivation of the ophthalmic medical industry.

Adhering to the concept of open collaboration in scientific research, Aier Ophthalmology continues to deepen academic exchanges at home and abroad, actively building a high-level academic platform covering the global ophthalmology field. By hosting and participating in various academic forums, special seminars, and professional exchange activities, we continuously strengthen dialogue and collaboration with global ophthalmic experts, deepen exchanges on cutting-edge technologies, clinical practices, and industry common issues, promote knowledge sharing, mutual learning of achievements, and collaborative innovation, and gather more wisdom and strength for the high-quality development of eye health.

In the medical field, digital new infrastructure is becoming a key force in solving the imbalance of medical resources and promoting inclusive healthcare. Aier Ophthalmology actively responds to the national strategy, upgrading artificial intelligence from a single point of application to the core strategy of the group, leading the digital transformation of eye health with "digital ophthalmology" as the core, and building a complete digital ophthalmology system covering infrastructure, data governance, model research and development, and full scenario applications. It unleashes medical potential in terms of quality, efficiency, and accessibility, accelerating the transformation from an "ophthalmic hospital" to a "full lifecycle eye health management platform".

Relying on the increasingly mature digital ophthalmology system, Aier Ophthalmology has accelerated the breaking down of medical barriers and achieved a deep integration of technology empowerment and public welfare. For example, equipping township health centers with fundus AI cameras to further enhance the ability of grassroots doctors to identify, diagnose, and manage high-risk populations; For difficult cases, the remote diagnosis and treatment platform system allows Aier ophthalmic experts to access real-time imaging diagnosis information, conduct remote consultations, and efficiently solve the difficulties of difficult eye disease diagnosis and treatment. Through continuous iteration of digital ophthalmic technology, Aier Ophthalmology is continuously promoting the precise sinking of eye disease prevention and treatment technology, significantly improving the accessibility and affordability of primary eye health services, and enabling high-quality eye health services to benefit more people.

In the future, Aier Ophthalmology will continue to leverage the advantages of collaborative innovation in medical education, research, and production, deeply cultivate digital ophthalmology construction, promote the deep integration of cutting-edge technology and medical practice, continuously expand the boundaries of ophthalmic diagnosis and treatment and services, enhance precision diagnosis and treatment and achievement transformation capabilities, and inject stronger momentum into high-quality development and industry innovation and upgrading.